Loading…
Optimal Structure Requirements for Pluronic Block Copolymers in Modifying P-glycoprotein Drug Efflux Transporter Activity in Bovine Brain Microvessel Endothelial Cells
Pluronic block copolymer P85 was shown to inhibit the P-glycoprotein (Pgp) drug efflux system and to increase the permeability of a broad spectrum of drugs in the blood-brain barrier (BBB). However, there is an entire series of Pluronics varying in lengths of propylene oxide and ethylene oxide and o...
Saved in:
Published in: | The Journal of pharmacology and experimental therapeutics 2003-02, Vol.304 (2), p.845-854 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Pluronic block copolymer P85 was shown to inhibit the P-glycoprotein (Pgp) drug efflux system and to increase the permeability
of a broad spectrum of drugs in the blood-brain barrier (BBB). However, there is an entire series of Pluronics varying in
lengths of propylene oxide and ethylene oxide and overall lipophilicity. This study identifies those structural characteristics
of Pluronics required for maximal impact on drug efflux transporter activity in bovine brain microvessel endothelial cells
(BBMECs). Using a wide range of block copolymers, differing in hydrophilic-lipophilic balance (HLB), this study shows that
lipophilic Pluronics with intermediate length of propylene oxide block (from 30 to 60 units) and HLB |
---|---|
ISSN: | 0022-3565 1521-0103 |
DOI: | 10.1124/jpet.102.043307 |